CDH2 and CDH11 act as regulators of stem cell fate decisions  by Alimperti, Stella & Andreadis, Stelios T.
Ava i l ab l e on l i ne a t www.sc i enced i r ec t . com
ScienceDirect
www.e l sev i e r . com / l oca te / s c r
Stem Cell Research (2015) 14, 270–282REVIEWCDH2 and CDH11 act as regulators of stem
cell fate decisions
Stella Alimperti a, Stelios T. Andreadis a,b,⁎a Bioengineering Laboratory, Department of Chemical and Biological Engineering, University at Buffalo, State University of
New York, Amherst, NY 14260-4200, USA
b Center of Excellence in Bioinformatics and Life Sciences, Buffalo, NY 14203, USAReceived 18 September 2014; received in revised form 24 January 2015; accepted 10 February 2015
Available online 19 February 2015Abstract
Accumulating evidence suggests that the mechanical and biochemical signals originating from cell–cell adhesion are critical for
stem cell lineage specification. In this review, we focus on the role of cadherin mediated signaling in development and stem
cell differentiation, with emphasis on two well-known cadherins, cadherin-2 (CDH2) (N-cadherin) and cadherin-11 (CDH11)
(OB-cadherin). We summarize the existing knowledge regarding the role of CDH2 and CDH11 during development and
differentiation in vivo and in vitro. We also discuss engineering strategies to control stem cell fate decisions by fine-tuning the
extent of cell–cell adhesion through surface chemistry and microtopology. These studies may be greatly facilitated by novel
strategies that enable monitoring of stem cell specification in real time. We expect that better understanding of how
intercellular adhesion signaling affects lineage specification may impact biomaterial and scaffold design to control stem cell
fate decisions in three-dimensional context with potential implications for tissue engineering and regenerative medicine.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Intercellular adhesion plays important role in tissue archi-
tecture and morphogenesis by controlling the assembly of
individual cells into the three-dimensional tissues (Cavallaro
and Dejana, 2011). Cell–cell or cell–matrix interactions are
mediated by cell adhesion molecules (CAMs) including
cadherins, integrins, selectins and immunoglobulin-like
CAMs, and regulate multiple aspects of cellular behavior
including proliferation, differentiation, apoptosis, cell po-
larity (Cavallaro and Dejana, 2011; Niessen and Gumbiner,
2002), embryonic stem cell self-renewal and differentiation
(Li et al., 2012) and overall, the maintenance of tissue
integrity (Harris and Tepass, 2010).
Cadherins represent one class of CAMs that mediate Ca2+
dependent homophilic interactions between cells, through
formation of intercellular connections or otherwise known as
adherens junctions (AJs). The most well studied cadherins
are the classical vertebrate cadherins that have been named
based on the tissue in which they are expressed. Neuronal
cells mostly express N-cadherin (CDH2), while epithelial
cells highly express E-cadherin (CDH1). Among the
non-classical cadherins, VE-cadherin (CDH5) is expressed in
endothelial cells and OB-cadherin (CDH11) is expressed in
osteoblasts. However, the expression level of cadherins may
vary during different cellular processes, especially those
that involve transition from one cellular state to another.
For example, it is well-established that the process of
epithelial to mesenchymal transition (EMT) is characterized
by augmented expression of CDH2 and CDH11 and diminished
expression of CDH1 (Kimura et al., 1995; Zeisberg and
Neilson, 2009; Tomita et al., 2000). Recent studies suggest
that cadherin expression and cell–cell adhesion may also be
critical in other transitions between cellular states such as
lineage specification of stem cells or reprogramming of adult
cells to a pluripotent state (Redmer et al., 2011; Alimperti
et al., 2014a).
Stem cell differentiation is affected by many soluble and
insoluble signals in their local microenvironment. In addition
to soluble growth factors, a number of elegant studies
implicated cell-extracellular matrix (ECM) interactions and
substrate mechanics in stem cell lineage commitment
(Buxboim and Discher, 2010; Buxboim et al., 2010; Engler
et al., 2006, 2007; Gao et al., 2010; McBeath et al., 2004;
Treiser et al., 2010; Gilbert et al., 2010). However, the
mechanical and biochemical signals originating from cell–
cell adhesion remain relatively unexplored in this context.
Recent studies implicated adherens junctions in the main-
tenance of embryonic stem cell self-renewal potential,cellular reprogramming, hematopoietic stem cell engraft-
ment and mesenchymal stem cell (MSC) differentiation into
the muscle (Redmer et al., 2011; Alimperti et al., 2014a;
Hosokawa et al., 2010a). Here we provide a brief review on
the role of cadherins, in particular CDH2 and CDH11, in
development and stem cell fate decisions. This is a relatively
nascent field of stem cell biology that has the potential to
guide the development of novel strategies to control stem
cell fate decisions as well as to inspire biomimetic design of
nanomaterials for tissue engineering and regeneration.Adherens junctions: signal transduction and
mechanosensing
In general, classical cadherins including CDH2 and CDH11
have a common cytoplasmic domain and an ectodomain
containing five tandem extracellular cadherin (EC) domains
(Brasch et al., 2012) (Fig. 1). The EC domains contain Ca2+
binding sites in which three Ca2+ ions work as inter-domain
linkers, stabilizing the ectodomain structure and protecting
it from proteolysis (Boggon et al., 2002; Pokutta et al., 1994;
Takeichi, 1991). The outermost EC1 domain regulates
cadherin–cadherin interactions between adjacent cells,
resulting in formation of adherens junctions between
parallel opposing plasma membranes (Shapiro and Weis,
2009). Specifically, CDH2 and CDH11 are mostly expressed in
mesenchymal type cells such as fibroblasts and cardiac cells
and mediate intercellular adhesion between cells of the
same type, e.g., myofibroblasts, or different cell types,
e.g., between myofibroblasts and cardiac cells (Thompson
et al., 2014).
Interaction of cadherin–cadherin may lead to intercellu-
lar activation of cellular pathways, initiating through
lamellipodial protrusions and is followed by the cadherin–
catenin–actin cluster formation. The association of cadherin
with catenin promotes and stabilizes the AJs, while actin
polymerization leads to AJ expansion and maturation,
further stabilizing and aligning adjacent cell membranes
(Harris and Tepass, 2010). In particular, β-catenin binds to
the cadherin cytoplasmic tail and interacts with α-catenin,
which modulates the actin cytoskeleton (Cavallaro and
Dejana, 2011; Stepniak et al., 2009). The intracellular
domains of the cadherins also bind to p120 catenin, which
links cadherin to microtubules (Harris and Tepass, 2010) and
regulates GTPases such as Rho, Rac1 and Cdc42 (Cavallaro
and Dejana, 2011; Reynolds and Carnahan, 2004; Yonemura,
2011; Grosheva et al., 2001; Anastasiadis et al., 2000;
Anastasiadis and Reynolds, 2000; Noren et al., 2000) (Fig. 1).
Figure 1 Schematic representation of cadherin structure and downstream signaling. Cadherins contain five extra cellular (EC)
domains linked by Ca2+ binding sites and one intracellular domain. Classical cadherin partners include to β-catenin, which binds to
α-catenin linking the AJ complex to the actin cytoskeleton, as well as p120 catenin, which regulates small GTPases such as Rho, Rac,
and Cdc42. Ultimately, cadherin engagement regulates many cellular processes including proliferation, migration and stem cell
differentiation.
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Cdc42 affects AJ maintenance (Yap and Kovacs, 2003; Braga,
2002). The function of GTPases is linked to cadherins and
may control various cellular processes including polariza-
tion, migration and apoptosis. Specifically, CDH2 regulates
spatially polarized signals through distinct p120 and
β-catenin-dependent signaling pathways (Ouyang et al.,
2013). Interestingly, CDH2 mediated cell adhesion is impor-
tant for collective 3D migration (Peglion et al., 2014; Shih and
Yamada, 2012a, b), while CDH11 is required for directional
migration in vivo (Becker et al., 2013).
Several reports showed that cadherins are affected by
growth factors and activate signaling pathways as a result of
physical interactions with growth factor receptors. On
exposure to shear stress, VE-cadherin binds to platelet
endothelial cell adhesion molecule (PECAM-1) and vascular
endothelial growth factor receptor (VEGFR2) and this complex
may lead to integrin activation and actin cytoskeleton
reorganization (Shay-Salit et al., 2002; Tzima et al., 2005).
Epidermal growth factor receptor (EGFR) forms a complex
with CDH1, leading to activation of the mitogen-activated
protein kinases (MAPK) pathway in epithelial cells (Pece and
Gutkind, 2000; Hoschuetzky et al., 1994) with implications for
cell survival (Shen and Kramer, 2004) or EMT (Wendt et al.,
2010; Jia et al., 2012). Fibroblast growth factor receptors
(FGFRs) were shown to stimulate CDH2 during neurite
outgrowth (Williams et al., 1994, 2002), while FGF plays a
critical role in the maintenance of vascular integrity by
enhancing the stability of VE-cadherin at AJ sites (Hatanaka
et al., 2012). Hepatocyte growth factor (HGF) modulates
the expression of the cell adhesion molecule VE-cadherinand consequently endothelial cell motility, migration and
angiogenesis (Martin et al., 2001). Finally, transforming
growth factor beta 1 (TGF-β1) increases keratinocyte
migration by increasing the levels of CDH2 and this action
is counteracted by EGF (Diamond et al., 2008).
Several reports have shown that cadherins are not only
chemically but also mechanically regulated. Recently, our
laboratory showed that substrate stiffness regulated AJ
formation between epithelial cells in two-dimensional (2D)
cultures and in three-dimensional (3D) epidermal tissues in vivo
and in vitro by regulating the phosphorylation levels of the
c-Janus N-terminal kinase (JNK) (You et al., 2013). Rigid
substrates led to JNK activation and AJ disassembly, while soft
matrices suppressed JNK activity leading to AJ formation. The
results held true in 3D bioengineered epidermis as well as in the
epidermis of knockout (jnk1−/− or jnk2−/−) mice. In conclusion,
we discovered that the JNK pathway mediated the effects of
substrate stiffness on AJ formation in 2D and 3D context in vitro
as well in vivo. These findings shed light into the mechanisms
of AJ formation and dissolution during tissue development and
may provide novel guiding principles to control cell–cell vs.
cell–substrate adhesion in 3D as a therapeutic strategy to
promote tissue regeneration or inhibit tumor invasion.
Even though substrate stiffness and tethering is mostly
known to affect focal adhesions (Trappmann et al., 2012;
Wen et al., 2014; Levental et al., 2009), increasing evidence
suggests that it may also affect cadherin-mediated inter-
cellular adhesion (Smutny and Yap, 2010; Ladoux et al., 2010).
Substrate stiffness was implicated in cadherin-dependent
collective cell migration through myosin-II contractility (Ng et
al., 2012). CDH2 is considered a mechano-responsive adhesion
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comparable in magnitude to those sustained by integrin–ECM
coupling (Chopra et al., 2011). In general, stiffer substrates lead
to greater traction forces, larger cell-spread areas and better
developed CDH2 junctions (Ladoux et al., 2010).
Finally, better understanding of cadherin based cell–cell
interactions may be useful in development of scaffold-free
tissue engineering strategies (Dvir-Ginzberg et al., 2003;
Mertsching et al., 2005; Place et al., 2009). These strategies
rely on directed cellular self-assembly using scaffold-free
techniques including formation of spheroids or bioprinting,
instead of biomaterial scaffolds to guide tissue formation,
3D organization and structure (Schiele et al., 2013; Baraniak
and McDevitt, 2012; Norotte et al., 2009; Stevens et al.,
2009; Napolitano et al., 2007).
The role of CDH2 and CDH11 during develop-
ment and morphogenesis
In the early stages of embryogenesis, the trophoblast giant
cells are devoid of CDH2 or CDH11 (Simonneau et al., 1995).
During gastrulation, the process in generating the three
germ cell layers, CDH11 is highly expressed enabling spatial
recognition and segregation of cells as they move to
generate primitive tissue structures (Gumbiner, 1996;
Guillot and Lecuit, 2013; Rossant and Tam, 2009). At later
stages as cells undergo EMT, CDH1 is downregulated, while
CDH2 is upregulated and is important for proper left–right
axis development (Garcia-Castro et al., 2000). In general,
gastrulation gives rise to three germ layers: ectoderm,
endoderm and mesoderm. CDH2 and CDH11 are absent in
cells of the endodermal lineage (Simonneau et al., 1995) but
play important roles in the development of ectodermal and
mesodermal lineages as described below.
Ectodermal lineage
The ectoderm is the first germ layer to emerge during
gastrulation. In vertebrates, the ectoderm is responsible for
the formation of the nervous system and spinal cord. The
nervous system is formed during neurulation, when the
neural tube is transformed into a primitive structure and
eventually into the central nervous system. Early in neural
tube development, the notochord and the dorsal aorta do
not express CDH11, which is expressed during the later
stages of neural tube formation and is important for brain
and spinal cord development (Suzuki et al., 1997; Marthiens
et al., 2002a). CDH11 is expressed in the limbic system of the
brain, particularly in the hippocampus where it is thought to
participate in the organization and stabilization of synaptic
connections (Manabe et al., 2000). It is also expressed in the
peripheral nervous system and, in particular, in motor and
sensory axons during the period of active nerve elongation
and path finding (Marthiens et al., 2002b; Padilla et al.,
1998). CDH2 is present during neuroectoderm formation and
is important for nervous system development (Kadowaki et
al., 2007; Redies, 2000). CDH2 knockout mice die on day 10
of gestation due to heart defects and malformed neural
tubes, although tissue development appears normal up to
this stage (Radice et al., 1997). Others reported that CDH2 is
involved in neuronal circuit maturation by contributing toaxonal extension (Kimura et al., 1995). Finally, both CDH2
and CDH11 were shown to regulate neurite outgrowth
through FGFR (Boscher and Mege, 2008),phosphoinositide
phospholipase C (PLC) and CAM kinase pathways (Bixby et
al., 1994; Riehl et al., 1996).
Mesodermal lineage
Mesoderm is the middle developmental layer between the
ectoderm and endoderm, which gives rise to the skeleton,
muscle, heart and bones. In early embryos, both CDH2 and
CDH11 are found in the mesoderm (Takeichi, 1991; Hatta and
Takeichi, 1986) albeit with different expression patterns. The
head mesoderm expresses higher levels of CDH11 comparing
to CDH2, while branchial arches express only CDH11 (Kimura
et al., 1995). CDH11 is present in all mesenchymal cells
throughout the embryo, such as mesenchymal cells of the
stomach, intestine, pharynx, lung bud and shaft of the ribs
(Simonneau et al., 1995; Kuijpers et al., 2007; Monahan et al.,
2007; Halbleib and Nelson, 2006) as well as mesenchymal stem
cells originating from the pre-chondal and paraxial mesoderm
and from neuroectodermal neural crest cells. CDH2 is also
expressed in all mesenchymal and mesothelial tissues
(Derycke and Bracke, 2004) and its expression is regulated by
platelet-derived growth factor (PDGF) and FGF signaling (Yang
et al., 2008).
The role of CDH2 and CDH11 in mesenchymal
stem cell differentiation
Recently cadherins were found to regulate stem cell mainte-
nance and differentiation. CDH1 was necessary for maintaining
pluripotency of embryonic stem cells as well as for cellular
reprogramming, where ectopic expression of CDH1 could
substitute for the pluripotency factor Oct4 (Redmer et al.,
2011). Interestingly, CDH2was implicated in long-term engraft-
ment of hematopoietic stem cells and establishment of
hematopoiesis after bone marrow transplantation (Hosokawa
et al., 2010a) but its exact role remains controversial. Some
studies suggested that it might be necessary as inhibition of
cadherin-mediated homophilic and heterophilic adhesion
reduced the long-term repopulation activity of hematopoietic
stem cells (HSCs) (Hosokawa et al., 2010b). However, others
reported that CDH2 conditional knockout mice do not show
defects in HSC number or function (Kiel et al., 2009).
On the other hand, accumulating evidence suggests that
both cadherins play important roles in MSC differentiation.
MSCs provide an excellent cell source for cellular therapies to
treat bone and cartilage disorders (Horwitz et al., 2002;
Wakitani et al., 2002), myocardial infarction, stroke (Li et al.,
2005; Wang et al., 2002), rheumatoid arthritis (Augello et al.,
2007), acute lung injury (Gupta et al., 2007; Ortiz et al.,
2007), graft-versus-host disease (Dander et al., 2012) and
skin-graft rejection (Bartholomew et al., 2002) among others.
The use of MSCs for tissue repair requires the migration and
homing to the site of damaged tissue and it has been shown
that both the migratory and proliferation potential of these
cells are affected by CDH2 and CDH11 (Xu et al., 2012; Theisen
et al., 2007). MSCs have also been shown to have differenti-
ation potential and anti-inflammatory properties (Myers et
al., 2010), which are enhanced when cultured as 3D spheroid
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Interestingly, both CDH2 and CDH11were shown to be critical in
the response of synovial fibroblasts to inflammation (Agarwal
and Brenner, 2006; Chang et al., 2011), suggesting that
cadherins may also be important in mediating the
anti-inflammatory effects of MSCs. Finally, CDH2 and CDH11
have been shown to be critical for MSC differentiation and their
expression levels are regulated differently in osteogenic,
chondrogenic or myogenic lineages as described below (Fig. 2).Osteogenic lineage
CDH2 and CDH11 are highly expressed during MSC osteogenic
differentiation (Ferrari et al., 2000) and several pro-
osteogenic factors are known to affect their expression. For
example, well-known osteogenic inducers, such as bone
morphogenetic protein 2 (BMP-2), parathyroid hormone
(PTH), bFGF and phorbol ester increased the levels of these
cadherins (Cheng et al., 1998; Suva et al., 1994; Debiais et al.,
2001). On the other hand, vitamin D decreased expression of
CDH2 (Luegmayr et al., 2000) and dexamethasone inhibited
the expression of both CDH2 and CDH11 mRNA in human
osteoprogenitor marrow stromal cells (BMC) (Lecanda et al.,
2000). Interestingly, both CDH2 and CDH11 were downregu-
lated in mature osteocytes (Marie, 2002).
Loss-of-function studies provided definitive data supporting
the role of both cadherins in bone formation. Blocking of
CDH2 or CDH11 with inhibitory peptides prevented osteoblasticFigure 2 Schematic representation of CDH2 and CDH11 expression d
during MSC commitment, differentiation and maturation towards (A
lineages. Upward or downward pointing arrows indicate increased ordifferentiation in vitro (Cheng et al., 1998; Marie, 2002; Kii et
al., 2004). In agreement, CDH11 knockout null mice showed
modest osteopenia by three months of age as signified by
decreased mineralizing surface and trabecular bone volume
(Kawaguchi et al., 2001a). The role of each cadherin in
osteogenesis was further dissected by using double knockout
mice (Chd2+/−;Cdh11−/−) and showed that although both CDH2
and CDH11 are important for osteogenesis, their contributions
were mediated by distinct mechanisms. Specifically, CDH11
was pro-osteogenic but dispensable for postnatal skeletal
growth; on the other hand, CDH2 was necessary for maintain-
ing the precursor osteoblast pool (Di Benedetto et al., 2010).
This result might explain why overexpression of CDH2
promoted migration but inhibited osteogenesis as evidenced
by decreased expression of osteogenic genes osteopontin,
osteocalcin, runt-related transcription factor 2 (RUNX2),
alkaline phosphatase (ALP) and BMP-2, as well as ALP activity
and calcium deposition in BM-MSC (Xu et al., 2012).Chondrogenic lineage
During chondrogenesis CDH2 and Sox9 were upregulated by
the action of paracrine factors like TGF-β, FGFs, or BMPs,
and the transcription factor Sox9 further increased the CDH2
promoter activity (Tuan, 2003). CDH2 mediated cell–cell
interactions and increased MSC aggregation, which in turn
promoted differentiation into the chondrogenic lineage
(Goldring et al., 2006; Quintana et al., 2009). CDH2 wasuring MSC lineage commitment. CDH2 and CDH11 expression levels
) osteogenic; (B) chondrogenic; (C) adipogenic; or (D) myogenic
decreased expression, respectively.
275N-Cadherin and Cadherin-11 in Stem Cell Lineage Specificationrequired for the initial condensation phase but decreased
significantly during terminal chondrogenic differentiation
(Oberlender and Tuan, 1994; Woods et al., 2007). In
agreement, it has been reported that the cleavage of CDH2
was required during chondrogenic differentiation (Nakazora
et al., 2010), while inhibition of commitment to chondrogenic
lineage by the Wnt7a inhibitor led to enhanced CDH2
expression and stabilization of AJs (Tufan and Tuan, 2001;
Tufan et al., 2002a, b). Interestingly, loss of CDH2 led to
increased levels of CDH11, suggesting that compensatory
mechanisms might be at work (Luo et al., 2005).
Adipogenic lineage
During adipogenesis, CDH2 and CDH11 were downregulated
and mature adipocytes did not express either of cadherin
(Shin et al., 2000; Kawaguchi et al., 2001b). In addition,
CDH11 knockdown induced adipogenic gene expression (e.g.
peroxisome proliferator-activated receptor γ (PPARγ)) and
differentiation, suggesting that CDH11 might inhibit
adipogenesis.
Myogenic lineage
CDH2 and CDH11 are also important during myogenic
differentiation. High cell density was shown to promote
myoblast differentiation, suggesting that cadherin mediated
cell–cell contact might affect myogenesis (Borghi and James
Nelson, 2009; Rougon and Hobert, 2003). CDH2 and CDH11Figure 3 CDH11 mediated AJ formation promotes MSC differentiat
activates the ROCK pathway, which in turn activates SRF leading to
CDH11 expression through a positive feedback loop further promoti
TGF-β1 expression further promoting SMC differentiation (D) througalso play important role in wound healing when fibroblasts
turn into myofibroblasts to increase wound contraction and
promote wound closure (Kuijpers et al., 2007; Hinz et al.,
2001a, b, 2004; Hinz and Gabbiani, 2003). Interestingly,
CDH11 was upregulated in vascular smooth muscle cells
(SMCs) in response to injury, while its inhibition reduced SMC
proliferation and migration (Monahan et al., 2007).
Recently, our group reported that CDH11 but not CDH2 was
necessary for MSC differentiation into SMCs (Alimperti et al.,
2014a) (Fig. 3). CDH11 engagement regulated MSC to SMC
differentiation via two pathways. One pathway was depen-
dent on TGF-β receptor II (TGF-βRII) but independent of
SMAD2/3. The second pathway involved activation of
Rho-associated protein kinase (ROCK), which in turn induced
expression of serum response factor (SRF) and SMC proteins,
such as alpha smooth muscle actin (αSMA), calponin and
myosin heavy chain (MYH11). Increased expression of SRF
resulted in increased expression of CDH11, indicating the
presence of a positive feedback loop that led to increased
CDH11 engagement and subsequent commitment of MSC to
the SMC fate (Fig. 3). Experiments with CDH11-null (Cdh11−/−)
mice verified the role of CDH11 in SMC function as vascular and
urogenital tissues of these animals exhibited significantly
reduced levels of SMC proteins and most notably, diminished
contractility as compared to wild-type controls. These
findings are novel and surprising as Cdh11−/− mice develop
normally, are fertile and display no obvious phenotype other
than modest osteopenia (Kawaguchi et al., 2001a, b; Shin et
al., 2000) and decreased pulmonary fibrosis after lung injury
(Schneider et al., 2012). More work is required to understandion into SMC (Alimperti et al., 2014a). (A) Engagement of CDH11
increased expression of SMC genes. (B) SRF controls the level of
ng intercellular adhesion. (C) CDH11 engagement also increases
h a Smad2/3 independent pathway.
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the potential implications of CDH11 loss in cardiovascular,
urogenital, gastrointestinal and other SMC containing tissues.Engineering cell–cell adhesion to direct stem
cell fate decisions
The findings that we described above show that CDH2 and
CDH11 play important roles in stem cell lineage specification,
and therefore, could be used to develop technologies to control
stem cell differentiation by exploiting cell–cell interactions. To
this end, we propose the following strategies (Table 1) to
capitalize on the effects of cadherin-mediated intercellular
adhesion: (i) Engineering cadherin surfaces to control stem cell
differentiation; and (ii) Engineering surface microtopology to
control the extent of cell–cell adhesion and signaling.Engineering cadherin surfaces to control stem cell
differentiation
It has been shown that immobilized cadherins induced
similar signaling cascades in epithelial cells as CDH1
engagement during cell–cell contact. Cadherin immobiliza-
tion was facilitated by generating fusion proteins between
cadherins with the Fc antibody fragment that enables
protein immobilization to the surface. In addition, to
generating functional surfaces, immobilized cadherins can
be used to distinguish cadherin-mediated signaling pathways
from pathways activated by the engagement of other
junctional proteins, e.g., connexins, which usually follows
AJ formation during cell–cell contact (Kovacs et al., 2002a).
This approach has been used to immobilize several
cadherins including CDH1, CDH2 and CDH11 to regulate cellular
behavior. Specifically, CDH1-Fc activated Rac1 and decreased
RhoA activity in epithelial cells (Kovacs et al., 2002a, b; Noren
et al., 2001) and improved hepatocyte DNA synthesis and
proliferation (Brieva and Moghe, 2004a, b). Similarly, immobi-
lization of CDH2-Fc retained the adhesive properties of native
CDH2, resulting in recruitment of β-catenin, α-catenin and
p120 at the cell–cell contact sites (Lambert et al., 2000).
CDH2-Fc coated beads triggered myoblast maturation as
evidenced by increased expression of myogenic regulators,
such as SRF (Charrasse et al., 2002; Gavard et al., 2004).
Interestingly, CDH2 in lipid bilayer membranes induced
mesenchymal condensation of osteochondrogenic progenitors
and suppressed adipogenic differentiation (Evans et al., 2013).
Likewise, CDH11-Fc proteins formed dimers that were shown to
be functional i.e. engaged in strong homotypic CDH11
interactions (Pittet et al., 2008) and promoted binding of
CDH11-expressing L cells (Pittet et al., 2008; Lira et al., 2008).
Also, culture of MSCs on surface immobilized fusion protein
between a fibronectin domain (rFN) and CDH11 (rFN/CDH11)
significantly enhanced osteogenic differentiation (Zhang et al.,
2009). Finally, preliminary experiments in our laboratory
showed that immobilized cadherins promoted MSC differenti-
ation into SMC cells in a dose dependent manner, thereby
providing control of differentiation by surface presentation and
density. Collectively, these studies suggest the cadherin
immobilization can be employed to direct and/or fine tune
stem cell fate decisions and therefore, can be a useful strategy
277N-Cadherin and Cadherin-11 in Stem Cell Lineage Specificationenabling functionalization of biomaterial scaffolds for tissue
engineering and regenerative medicine.Engineering surface microtopology to control the
extent of cell–cell adhesion and signaling
Microfabrication technology offers the possibility to control
the extent cell–cell adhesion at the micro- or nano-meter
scale. This approach has been used extensively to control
cell–matrix interactions, which have been shown to be
critical in stem cell differentiation (Engler et al., 2004,
2006, 2007; Griffin et al., 2004; Discher et al., 2005; Guilak
et al., 2009). Fewer studies have used geometric micro-
patterning to control the extent of cell–cell adhesion and
evaluate its effects on stem cell differentiation (Chin et al.,
2004).
It was shown that the size of micro-islands correlated
with the level of cell spreading and CDH2 expression leading
to MSC differentiation into the myogenic or chondrogenic
lineages on the larger islands but adipogenic lineage on the
small ones (Gao et al., 2010). Similarly, by controlling the
geometry and size of micro-islands it was shown that
increased cell contact increased the extent of osteogenic
differentiation (Tang et al., 2010; Wang et al., 2013).
However, attempts to control cell–cell interactions by
varying the size of micropatterns are compounded by the
fact that cell density and therefore the degree of cell
spreading change with island size.Thus, the separation of
the effects of cell-cell vs. cell-substrate adhesion becomes
challenging. Interestingly, novel geometries have been
employed to control the extent of cell–cell contact
independent of cell density or the cell spreading area
(Gray et al., 2008; Nelson et al., 2007; Charest et al.,
2009), and therefore, may be used to determine the
relationship between the extent of intercellular adhesion
and stem cell fate commitment.Monitoring intercellular adhesion mediated
stem cell lineage specification in real time
Understanding how intercellular adhesion affects stem cell
fate decisions requires methods to interrogate stem cell
differentiation in real time and in a quantitative manner. In
particular, methods to monitor individual cells may be
particularly useful in experiments that involve small num-
bers of cells on micropatterned surfaces, thereby making
traditional assays, such as Western Blot and polymerase
chain reaction (PCR) challenging. In addition, monitoring
single cells is useful in addressing issues of heterogeneity in
embryonic, induced pluripotent or adult stem cells
populations and therefore, in distinguishing between cells
with varying differentiation potential.
To this end, our laboratory developed LentiViral Arrays
(LVA) to monitor gene or pathway activation during stem cell
differentiation. We designed a novel lentiviral dual promoter
vector (LVDP) vector that enables quantitative measurements
of the activity of a gene promoter (Pr) or a transcription factor
(TF) binding site (Response Element, RE) independent of the
number of gene copies per cell (Tian and Andreadis, 2009). We
also designed a second lentiviral vector (shLVDP) that enablesdynamic monitoring of Pr/RE activity with concomitant gene
knockdown in a doxycycline (Dox)-regulatable manner,
thereby enabling discovery of genes that may be involved
in stem cell differentiation (Alimperti et al., 2012). In
addition, the envelope of lentiviral particles was engineered
to bind covalently to fibrin hydrogels during polymerization
(Padmashali and Andreadis, 2011; Raut et al., 2010), thereby
enabling generation of lentiviral arrays (LVA) that were
employed to measure the activity of several Pr/RE participat-
ing in the inflammatory response (Tian et al., 2010). More
recently, we generated a library of Pr/RE to monitor MSC
differentiation towards adipogenic, osteogenic, chondrogenic
or myogenic lineages and used it to identify novel pathways
that may be involved in lineage specification (Padmashali et
al., 2014; Moharil et al., submitted for publication). Poten-
tially, this technology may be combined with novel
microfabrication methods to determine how the extent of
intercellular adhesion influences stem cell specification
decisions of adult stem cells, cancer stem cells or hiPSC and
potentially also the pluripotency networks that are critical for
cellular reprogramming.Conclusion and future perspectives
Although many studies have focused on the effects of
substrate stiffness on stem cell biology, the role of intercel-
lular adhesion forces in guiding stem cell self-renewal or
differentiation has been relatively unexplored. In this review,
we focused on CDH2 and CDH11 as regulators of stem cell fate
decisions. Although evidence that cadherins are important has
been surfacing, more work is necessary to understand how
intercellular adhesion affects MSC differentiation and reveals
some of the molecular pathways guiding this process. These
studies may also provide design parameters for guiding MSC
fate by controlling the extent of cadherin-mediated adhesion
with implications for tissue engineering and regenerative
medicine.Acknowledgments
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